FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking
This article was originally published in The Tan Sheet
Executive Summary
A draft guidance on designing self-selection studies in support of Rx-to-OTC switches reflects FDA’s interest in drilling down for greater insight into consumers’ thought processes.
You may also be interested in...
FDA Self-Selection Study Guidance Calls For Complex Questions
Final guidance on Rx-to-OTC self-selection studies makes space for investigation of novel switches under NSURE by recommending researchers ask complex questions that “involve a higher level of understanding” of multiple label elements at once.
FDA Self-Selection Study Guidance Calls For Complex Questions
Final guidance on Rx-to-OTC self-selection studies makes space for investigation of novel switches under NSURE by recommending researchers ask complex questions that “involve a higher level of understanding” of multiple label elements at once.
FDA Self-Selection Study Guidance Calls For Complex Questions
Final guidance on Rx-to-OTC self-selection studies makes space for investigation of novel switches under NSURE by recommending researchers ask complex questions that “involve a higher level of understanding” of multiple label elements at once.